About this Research Topic
Respiratory tumors, encompassing cancers such as lung cancer, nasopharyngeal carcinoma, and laryngeal cancer, pose a significant health challenge. The development of respiratory tumors is primarily linked to prolonged exposure to polluted environments, with genetic factors also contributing to their etiology. Clinical manifestations of respiratory diseases exhibit diversity, rendering the detection of disease progression challenging, as it often unfolds insidiously and unpredictably.
Addressing this complexity, researchers underscore the imperative of identifying and validating biomarkers. These biomarkers traverse various domains, including molecular, genetic, and imaging-based markers, alongside an array of blood-derived proteins and cellular components. Recent strides in unearthing potential biomarkers for respiratory system tumors hold promise for reshaping disease management paradigms. Integration into clinical practice has the potential to redefine our approach, with early detection and precise prognosis guiding therapeutic interventions, fostering improved patient outcomes. These biomarkers, beyond their diagnostic prowess, assume a pivotal role in monitoring treatment responses, steering personalized therapeutic strategies, instilling a renewed sense of optimism for those navigating the challenges of respiratory tumors.
This Research Topic aims to curate avant-garde research on biomarkers in respiratory tumors, fostering collaboration among domain experts. By deepening our comprehension of disease pathogenesis and furnishing novel tools for clinical decision-making, biomarker research emerges as a beacon of hope for individuals grappling with the complexities of respiratory tumors. Researchers are invited to submit Original Research, Systematic Reviews, Mini-Reviews, Opinions, and Case Reports relevant to this collection. The research scope includes, but is not limited to the following:
- Identification of new biomarkers in respiratory tumors.
- Clinical applications of biomarkers in respiratory tumors.
- Biological functions regulated by tumor markers in respiratory tumors, including growth, differentiation, apoptosis, ferroptosis, autophagy, etc.
- Investigation of signaling pathways regulated by tumor markers in respiratory tumors.
- Advancements in immunotherapy, new molecular targeted therapy, new chemotherapy, and radiotherapy plans for respiratory tumors.
- Regulation of the microenvironment of respiratory tumors.
Addressing this complexity, researchers underscore the imperative of identifying and validating biomarkers. These biomarkers traverse various domains, including molecular, genetic, and imaging-based markers, alongside an array of blood-derived proteins and cellular components. Recent strides in unearthing potential biomarkers for respiratory system tumors hold promise for reshaping disease management paradigms. Integration into clinical practice has the potential to redefine our approach, with early detection and precise prognosis guiding therapeutic interventions, fostering improved patient outcomes. These biomarkers, beyond their diagnostic prowess, assume a pivotal role in monitoring treatment responses, steering personalized therapeutic strategies, instilling a renewed sense of optimism for those navigating the challenges of respiratory tumors.
This Research Topic aims to curate avant-garde research on biomarkers in respiratory tumors, fostering collaboration among domain experts. By deepening our comprehension of disease pathogenesis and furnishing novel tools for clinical decision-making, biomarker research emerges as a beacon of hope for individuals grappling with the complexities of respiratory tumors. Researchers are invited to submit Original Research, Systematic Reviews, Mini-Reviews, Opinions, and Case Reports relevant to this collection. The research scope includes, but is not limited to the following:
- Identification of new biomarkers in respiratory tumors.
- Clinical applications of biomarkers in respiratory tumors.
- Biological functions regulated by tumor markers in respiratory tumors, including growth, differentiation, apoptosis, ferroptosis, autophagy, etc.
- Investigation of signaling pathways regulated by tumor markers in respiratory tumors.
- Advancements in immunotherapy, new molecular targeted therapy, new chemotherapy, and radiotherapy plans for respiratory tumors.
- Regulation of the microenvironment of respiratory tumors.
Keywords: Nasopharyngeal carcinoma, Lung cancer, Tumor Marker, Immunotherapy, Molecular targeted therapy
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
